Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.

Sasaki H, Klotz LH, Sugar LM, Kiss A, Venkateswaran V.

Biochem Biophys Res Commun. 2015 Aug 28;464(3):848-54. doi: 10.1016/j.bbrc.2015.07.050. Epub 2015 Jul 13.

PMID:
26182875
2.

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.

Venier NA, Yamamoto T, Sugar LM, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V.

Prostate. 2015 Sep;75(12):1300-11. doi: 10.1002/pros.23013. Epub 2015 Jun 5.

PMID:
26047020
3.

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.

Colquhoun AJ, Venier NA, Vandersluis AD, Besla R, Sugar LM, Kiss A, Fleshner NE, Pollak M, Klotz LH, Venkateswaran V.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):346-52. doi: 10.1038/pcan.2012.16. Epub 2012 May 22.

PMID:
22614062
4.

Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.

Cervi D, Pak B, Venier NA, Sugar LM, Nam RK, Fleshner NE, Klotz LH, Venkateswaran V.

BMC Cancer. 2010 Jun 4;10:258. doi: 10.1186/1471-2407-10-258.

5.

A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.

Venkateswaran V, Klotz LH, Ramani M, Sugar LM, Jacob LE, Nam RK, Fleshner NE.

Cancer Prev Res (Phila). 2009 May;2(5):473-83. doi: 10.1158/1940-6207.CAPR-08-0124. Epub 2009 Apr 28.

6.

Systemic Erdheim-Chester disease.

Dickson BC, Pethe V, Chung CT, Howarth DJ, Bilbao JM, Fornasier VL, Streutker CJ, Sugar LM, Bapat B.

Virchows Arch. 2008 Feb;452(2):221-7. doi: 10.1007/s00428-007-0538-9. Epub 2008 Jan 10.

PMID:
18188596
7.

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M.

J Natl Cancer Inst. 2007 Dec 5;99(23):1793-800. Epub 2007 Nov 27.

PMID:
18042933
8.

Inflammation and prostate cancer.

Sugar LM.

Can J Urol. 2006 Feb;13 Suppl 1:46-7.

PMID:
16526982
9.

Antioxidants block prostate cancer in lady transgenic mice.

Venkateswaran V, Fleshner NE, Sugar LM, Klotz LH.

Cancer Res. 2004 Aug 15;64(16):5891-6.

10.

Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection.

Chidambaram M, Stigant CE, Sugar LM, Ramesh Prasad GV.

Clin Nephrol. 2002 Feb;57(2):154-7.

PMID:
11865821

Supplemental Content

Loading ...
Support Center